The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.
Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
Other videos you might like
Obesity Management Strategies in 2023
Watch time: 17m 7s
EASD 22: SURMOUNT-MMO: Tirzepatide in Obese Type II Diabetes Patients
Watch time: 07m 48s
SPLENDOR: Metabolic Surgery and Risk of MACE in NASH
RESPONSE-2: Long Term Outcomes of Lifestyle Programme in CAD Patients